The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Continuing Education Course #2: Current Understanding of Hemostasis
Open accessAbstract
The goal of this review is to briefly summarize the two primary pathways of hemostasis, primary hemostasis and secondary hemostasis, as well as to summarize anticoagulant mechanisms and fibrinolysis. In addition, this review will discuss pathologies of hemostasis and the mechanisms of the various drugs that are available to impact these pathways to prevent either thrombosis or bleeding. While many of the main drugs that are used to treat disorders of hemostasis have been used for decades, greater understanding of hemostasis has led to development of various new drugs that have come onto the market recently or are close to coming onto the market. Thus, improved understanding of hemostasis continues to lead to benefits for patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
A Cell-based Model of Hemostasis
Monroe, D., & Hoffman, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615947 · Cited by 1,542
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
The hemophilias--from royal genes to gene therapy
Mannucci, P. M., & Tuddenham, E. G. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442307 · Cited by 1,110 · cited 2×
“Depending on the mutation, hemophilia can be severe (<1% function), moderate (1–5%), or mild (5–20%) (Mannucci and Tuddenham 2001).”
BackgroundInherited Antithrombin Deficiency Causing Thrombophilia
Egeberg, O. (1965) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656297 · Cited by 1,030
Structural Basis of Collagen Recognition by Integrin α2β1
Emsley, J., Knight, C. G., Farndale, R. W., Barnes, M. J., & Liddington, R. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80622-4 · Cited by 1,005
A dual thrombin receptor system for platelet activation
Kahn, M. L., Zheng, Y.-W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R. V., Tam, C., & Coughlin, S. R. (1998) · Nature · doi:10.1038/29325 · Cited by 979
Surface-dependent reactions of the vitamin K-dependent enzyme complexes
Mann, K., Nesheim, M., Church, W., Haley, P., & Krishnaswamy, S. (1990) · Blood · doi:10.1182/blood.v76.1.1.1 · Cited by 879
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics
Xiao, T., Takagi, J., Coller, B. S., Wang, J.-H., & Springer, T. A. (2004) · Nature · doi:10.1038/nature02976 · Cited by 846
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.
Esmon, C. T., & Owen, W. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2249 · Cited by 830
Cited by
Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding
Hickman, D. A., Pawlowski, C. L., Sekhon, U. D. S., Marks, J., & Gupta, A. S. (2018) · Advanced Materials · doi:10.1002/adma.201700859 · Cited by 583
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
Chronic Diabetic Wounds and Their Treatment with Skin Substitutes
Holl, J., Kowalewski, C., Zimek, Z., Fiedor, P., Kaminski, A., Oldak, T., Moniuszko, M., & Eljaszewicz, A. (2021) · Cells · doi:10.3390/cells10030655 · Cited by 351
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms
Loo, J., Spittle, D. A., & Newnham, M. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216243 · Cited by 341
Eble, J. A. (2019) · Toxins · doi:10.3390/toxins11030136 · Cited by 82
Metadata
- Authors
- Gale, A. J.
- Venue
- Toxicologic Pathology
- Publisher
- SAGE Publications
- Published
- 2010-11-30
- Volume
- 39
- Issue
- 1
- Pages
- 273-280
- ISSN
- 0192-6233 (ISSN-L)
- 1533-1601
- OpenAlex
- W2117996963
- Cited by
- 376
- References
- 49
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Continuing Education Course #2: Current Understanding of Hemostasis. https://app.cochat.ai/papers/10.1177/0192623310389474
- The paper
- Gale, A. J. (2011). Continuing Education Course #2: Current Understanding of Hemostasis. Toxicologic Pathology. https://doi.org/10.1177/0192623310389474
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.